1. World Health Organization. Classification of diabetes mellitus. Geneva: World Health Organization; 2019.
2. American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care 2019;42:S13-28.
3. Koivusalo SB, Rönö K, Klemetti MM, Roine RP, Lindström J, Erkkola M, et al. Gestational diabetes mellitus can be prevented by lifestyle intervention: the Finnish Gestational Diabetes Prevention Study (RADIEL): a randomized controlled trial. Diabetes Care 2016;39:24-30.
7. Song C, Li J, Leng J, Ma RC, Yang X. Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials. Obes Rev 2016;17:960-9.
9. Cunningham FG, Leveno KJ, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Williams obstetrics. 25th ed. New York (NY): Mcgraw-hill; 2018.
10. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013.
11. Amreen S, Suneel A, Shetty A, Vasudeva A, Kumar P. Use of glycosylated HbA1c and random blood sugar as a screening tool for gestational diabetes mellitus in first trimester. Int J Reprod Contracept Obstet Gynecol 2018;7:524-8.
13. Siddiqui S, Waghdhare S, Goel C, Panda M, Soneja H, Sundar J, et al. Augmentation of IL-6 production contributes to development of gestational diabetes mellitus: an Indian study. Diabetes Metab Syndr 2019;13:895-9.
16. Yang Y, Liu L, Liu B, Li Q, Wang Z, Fan S, et al. Functional defects of regulatory T cell through interleukin 10 mediated mechanism in the induction of gestational diabetes mellitus. DNA Cell Biol 2018;37:278-85.
18. Šimják P, Cinkajzlová A, Anderlová K, Kloučková J, Kratochvílová H, Lacinová Z, et al. Changes in plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus. Physiol Res 2018;67:S531-42.
20. Rahnemaie FS, Zare E, Zaheri F, Abdi F. Effects of complementary medicine on successful breastfeeding and its associated issues in the postpartum period. Iran J Pediatr 2019;29:e80180.
21. Wang X, Liu J, Wang D, Zhu H, Kang L, Jiang J. Expression and correlation of Chemerin and FABP4 in peripheral blood of gestational diabetes mellitus patients. Exp Ther Med 2020;19:710-6.
22. Yu H, Liu Z, Dong S. Changes in intestinal flora, TNF-α, L-17, and IL-6 levels in patients with gestational diabetes mellitus. Eur J Inflamm; Forthcoming 2018.
23. Zhao X, Liu J, Shen L, Wang A, Wang R. Correlation between inflammatory markers (hs-CRP, TNF-α, IL-1β, IL-6, IL-18), glucose intolerance, and gestational diabetes mellitus in pregnant women. Int J Clin Exp Med 2018;11:8310-6.
24. Abell SK, Shorakae S, Harrison CL, Hiam D, MorenoAsso A, Stepto NK, et al. The association between dysregulated adipocytokines in early pregnancy and development of gestational diabetes. Diabetes Metab Res Rev 2017;33:e2926.
26. Bossick AS, Peters RM, Burmeister C, Kakumanu N, Shill JE, Cassidy-Bushrow AE. Antenatal inflammation and gestational diabetes mellitus risk among pregnant African-American women. J Reprod Immunol 2016;115:1-5.
27. Oztop N, Kusku-Kiraz Z, Dervisoglu E, Dinccag N, Genc S. The association of glycemic markers with plasma adipocytokine levels in women with gestational diabetes. J Diabetes Metab 2016;7:1000699.
28. Qu X, Yu H, Jia B, Yu X, Cui Q, Liu Z, et al. Association of downregulated HDAC 2 with the impaired mitochondrial function and cytokine secretion in the monocytes/macrophages from gestational diabetes mellitus patients. Cell Biol Int 2016;40:642-51.
29. Gümüş P, Özçaka Ö, Ceyhan-Öztürk B, Akcali A, Lappin DF, Buduneli N. Evaluation of biochemical parameters and local and systemic levels of osteoactive and B-cell stimulatory factors in gestational diabetes in the presence or absence of gingivitis. J Periodontol 2015;86:387-97.
31. Kim SY, Sy V, Araki T, Babushkin N, Huang D, Tan D, et al. Total adiponectin, but not inflammatory markers Creactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese-Americans. J Diabetes 2014;6:360-8.
32. Kuźmicki M, Telejko B, Lipińska D, Pliszka J, Wilk J, Wawrusiewicz-Kurylonek N, et al. The IL-6/IL-6R/sgp130 system and Th17 associated cytokines in patients with gestational diabetes. Endokrynol Pol 2014;65:169-75.
33. Nergiz S, Altınkaya ÖS, Küçük M, Yüksel H, Sezer SD, Kurt Ömürlü İ, et al. Circulating galanin and IL-6 concentrations in gestational diabetes mellitus. Gynecol Endocrinol 2014;30:236-40.
34. Özyer Ş, Engin-Üstün Y, Uzunlar Ö, Katar C, Danışman N. Inflammation and glycemic tolerance status in pregnancy: the role of maternal adiposity. Gynecol Obstet Invest 2014;78:53-8.
36. Abdel Gader AG, Khashoggi TY, Habib F, Awadallah SB. Haemostatic and cytokine changes in gestational diabetes mellitus. Gynecol Endocrinol 2011;27:356-60.
37. Morisset AS, Dubé MC, Côté JA, Robitaille J, Weisnagel SJ, Tchernof A. Circulating interleukin‐6 concentrations during and after gestational diabetes mellitus. Acta Obstet Gynecol Scand 2011;90:524-30.
38. Pöyhönen-Alho M, Ebeling P, Saarinen A, Kaaja R. Decreased variation of inflammatory markers in gestational diabetes. Diabetes Metab Res Rev 2011;27:269-76.
39. Kuzmicki M, Telejko B, Szamatowicz J, Zonenberg A, Nikolajuk A, Kretowski A, et al. High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecol Endocrinol 2009;25:258-63.
40. Harrison CL, Lombard CB, East C, Boyle J, Teede HJ. Risk stratification in early pregnancy for women at increased risk of gestational diabetes. Diabetes Res Clin Pract 2015;107:61-8.
41. Farrar D, Duley L, Dowswell T, Lawlor DA. Different strategies for diagnosing gestational diabetes to improve maternal and infant health. Cochrane Database Syst Rev 2017;8:CD007122.
42. Weinert LS. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups consensus panel. Diabetes Care 2010;33:e97.
43. Kleiblova P, Dostalova I, Bartlova M, Lacinova Z, Ticha I, Krejci V, et al. Expression of adipokines and estrogen receptors in adipose tissue and placenta of patients with gestational diabetes mellitus. Mol Cell Endocrinol 2010;314:150-6.
44. Khodabandehloo H, Gorgani-Firuzjaee S, Panahi G, Meshkani R. Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction. Transl Res 2016;167:228-56.
45. Sun D, Li F, Zhang Y, Xu X. Associations of the prepregnancy BMI and gestational BMI gain with pregnancy outcomes in Chinese women with gestational diabetes mellitus. Int J Clin Exp Med 2014;7:5784-9.
46. Vejrazkova D, Vcelak J, Vankova M, Lukasova P, Bradnova O, Halkova T, et al. Steroids and insulin resistance in pregnancy. J Steroid Biochem Mol Biol 2014;139:122-9.